Henan Lingrui Pharmaceutical Co Ltd (600285) — Cash Flow Quality Index
Henan Lingrui Pharmaceutical Co Ltd (600285) has a Cash Flow Quality Index of 0.79x as of September 2025. Operating cash flow of CN¥140.12 Million is below net income of CN¥176.55 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Henan Lingrui Pharmaceutical Co Ltd cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Henan Lingrui Pharmaceutical Co Ltd Cash Flow Quality Index (1999–2025)
Historical Cash Flow Quality Index for Henan Lingrui Pharmaceutical Co Ltd across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Henan Lingrui Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Henan Lingrui Pharmaceutical Co Ltd (1999–2025)
Year-by-year earnings quality comparison for Henan Lingrui Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Henan Lingrui Pharmaceutical Co Ltd market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.73x | CN¥553.88 Million | CN¥759.50 Million | ▼ -39.8% |
| 2024 | 1.21x | CN¥875.86 Million | CN¥722.58 Million | ▼ -15.3% |
| 2023 | 1.43x | CN¥813.43 Million | CN¥568.11 Million | ▼ -20.2% |
| 2022 | 1.79x | CN¥834.91 Million | CN¥465.33 Million | ▼ -23.1% |
| 2021 | 2.33x | CN¥845.69 Million | CN¥362.50 Million | ▲ +68.0% |
| 2020 | 1.39x | CN¥450.53 Million | CN¥324.38 Million | ▼ -9.6% |
| 2019 | 1.54x | CN¥450.15 Million | CN¥293.15 Million | ▼ -13.5% |
| 2018 | 1.78x | CN¥436.25 Million | CN¥245.77 Million | ▲ +276.8% |
| 2017 | 0.47x | CN¥105.97 Million | CN¥224.93 Million | ▲ +159.0% |
| 2016 | 0.18x | CN¥63.26 Million | CN¥347.72 Million | ▼ -84.5% |
| 2015 | 1.17x | CN¥156.82 Million | CN¥133.71 Million | ▼ -28.1% |
| 2014 | 1.63x | CN¥124.32 Million | CN¥76.22 Million | ▲ +35.1% |
| 2013 | 1.21x | CN¥127.27 Million | CN¥105.39 Million | ▲ +226.7% |
| 2012 | 0.37x | CN¥15.43 Million | CN¥41.76 Million | ▼ -72.9% |
| 2011 | 1.36x | CN¥40.49 Million | CN¥29.67 Million | ▲ +1769.3% |
| 2010 | -0.08x | CN¥-3.95 Million | CN¥48.34 Million | ▼ -101.8% |
| 2009 | 4.49x | CN¥132.61 Million | CN¥29.51 Million | ▲ +13.5% |
| 2008 | 3.96x | CN¥43.72 Million | CN¥11.04 Million | ▲ +1684.4% |
| 2007 | 0.22x | CN¥15.99 Million | CN¥72.03 Million | ▼ -91.0% |
| 2006 | 2.48x | CN¥26.76 Million | CN¥10.80 Million | ▲ +35.2% |
| 2005 | 1.83x | CN¥33.43 Million | CN¥18.23 Million | ▼ -27.7% |
| 2004 | 2.54x | CN¥35.51 Million | CN¥13.99 Million | ▲ +42.7% |
| 2003 | 1.78x | CN¥23.79 Million | CN¥13.38 Million | ▼ -66.8% |
| 2002 | 5.36x | CN¥69.41 Million | CN¥12.96 Million | ▲ +3843.4% |
| 2001 | 0.14x | CN¥3.41 Million | CN¥25.11 Million | ▲ +1.6% |
| 2000 | 0.13x | CN¥3.66 Million | CN¥27.40 Million | ▼ -69.3% |
| 1999 | 0.43x | CN¥4.81 Million | CN¥11.06 Million | — |